Assessment and analysis To assess the clinical response photographs were taken at the beginning of the therapy (baseline, i.e., day 0, at each sitting [4th and 8th weeks], and after 4 weeks of last therapy, i.e., at 12th week
to treat type 2 diabetes
Kopetz S , Chang G, Overman M, Eng C, Larson DW, Grothey A, Vauthey JN, Sargent D, McWilliams R
The peptide has been studied extensively across various organ systems, demonstrating cytoprotective effects in the gastrointestinal tract, liver, pancreas, heart, blood vessels, muscle, tendon, ligament, bone, and nervous system
According to meta-analysis data, hypothyroidism occurs in about 3.8% of patients treated with anti-CTLA-4, 3.9% with anti-PD-L1, 7.0% with anti-PD-1, and 13.2% with combination therapy
[DOI] [PubMed] [Google Scholar] 48.Twedt DC